![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Karger
E-ISSN: 1660-2862|16|1-2|22-25
ISSN: 1660-2854
Source: Neurodegenerative Diseases, Vol.16, Iss.1-2, 2016-0, pp. : 22-25
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Transition of Tau Protein from Disordered to Misordered in Alzheimer’s Disease
Neurodegenerative Diseases, Vol. 7, Iss. 1-3, 2010-02 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Immunomodulation of Memory-Impairing Protein Tau in Alzheimer’s Disease
Neurodegenerative Diseases, Vol. 10, Iss. 1-4, 2012-03 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Neurodegenerative Diseases, Vol. 13, Iss. 2-3, 2013-09 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Prefibrillar Tau Oligomers in Mild Cognitive Impairment and Alzheimer's Disease
Neurodegenerative Diseases, Vol. 13, Iss. 2-3, 2013-09 ,pp. :